Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
Imai H, Kuwako T, Kaira K, Masuda T, Miura Y, Seki K, Sakurai R, Utsugi M, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Ishizuka T, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M. Imai H, et al. Among authors: seki k. Cancer Chemother Pharmacol. 2017 Mar;79(3):497-505. doi: 10.1007/s00280-016-3232-2. Epub 2017 Feb 6. Cancer Chemother Pharmacol. 2017. PMID: 28168310 Free PMC article.
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations.
Kuwako T, Imai H, Masuda T, Miura Y, Seki K, Yoshino R, Kaira K, Utsugi M, Shimizu K, Sunaga N, Tomizawa Y, Ishihara S, Ishizuka T, Mogi A, Hisada T, Minato K, Takise A, Saito R, Yamada M. Kuwako T, et al. Among authors: seki k. Cancer Chemother Pharmacol. 2015 Oct;76(4):761-9. doi: 10.1007/s00280-015-2841-5. Epub 2015 Aug 8. Cancer Chemother Pharmacol. 2015. PMID: 26254024
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice.
Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F. Yatomi M, et al. Among authors: seki k. Physiol Rep. 2015 Dec;3(12):e12628. doi: 10.14814/phy2.12628. Physiol Rep. 2015. PMID: 26660549 Free PMC article.
The effects of concomitant GERD, dyspepsia, and rhinosinusitis on asthma symptoms and FeNO in asthmatic patients taking controller medications.
Ishizuka T, Hisada T, Kamide Y, Aoki H, Seki K, Honjo C, Sakai H, Kadowaki M, Umeda Y, Morikawa M, Anzai M, Ameshima S, Ishizaki T, Dobashi K, Yamada M, Kusano M. Ishizuka T, et al. Among authors: seki k. J Asthma Allergy. 2014 Sep 5;7:131-9. doi: 10.2147/JAA.S67062. eCollection 2014. J Asthma Allergy. 2014. PMID: 25228816 Free PMC article.
Diagnosing Oxalate Nephropathy on Kidney Biopsy Specimens.
Yamada K, Ikeda M, Koyama Y, Seki K, Kawaji A, Inoue T, Suzuki T. Yamada K, et al. Among authors: seki k. Kidney Med. 2024 Nov 12;7(1):100930. doi: 10.1016/j.xkme.2024.100930. eCollection 2025 Jan. Kidney Med. 2024. PMID: 39734605 Free PMC article. No abstract available.
1,399 results